DALLAS, Nov. 8, 2024 – With heart disease remaining the leading cause of death globally, particularly in the United States, there is an urgent need for innovative healthcare solutions. Risk factors like high blood pressure and obesity are contributing to these alarming statistics. To counter this trend, the American Heart Association Center for Health Technology & Innovation has spotlighted five promising start-ups in its 7th annual Health Tech Competition, aiming to accelerate advancements in cardiovascular care.

The competition serves as a dynamic platform where entrepreneurs can introduce groundbreaking technologies focused on treating and preventing heart disease and strokes. For over a century, the American Heart Association (AHA) has been at the forefront of driving healthcare innovations aimed at promoting healthier lives.

The finalists have developed solutions addressing a myriad of cardiovascular issues, including antithrombotic therapies, coronary artery disease, hypertension, and elektrophysiology – just to name a few. This year's competition is generously supported by the Laerdal Million Lives Fund, further emphasizing the commitment to improving patient outcomes through technological transformation.

Final presentations from these start-ups will take place at the American Heart Association's Scientific Sessions 2024, a key global event dedicated to sharing the latest advancements in cardiovascular science. Attendees can catch the action live at McCormick Place in Chicago on November 16-17, where a panel of esteemed judges will evaluate the concepts based on their validity, scientific rigor, and potential impact on patient health.

This year’s finalists include:

1. Flow Medical

- Based in Chicago, this start-up is leveraging smart technology for innovative cardiac solutions.

2. Heka Heart

- Located in San Mateo, California, Heka is focused on holistic approaches to heart health.

3. Powerful Medical

- This New York City start-up is dedicated to enhancing healthcare access through digital platforms.

4. Proton Intelligence

- Based in Vancouver, Canada, Proton is pushing the boundaries of predictive analytics in cardiovascular care.

5. Rheoxtech, Inc.

- Also based in Chicago, this company is working on revolutionary monitoring technology for heart patients.

The competition entails two main components: business and scientific "pitches." The judges, comprising top medical and business leaders, will assess the startups’ proposals and their potential to revolutionize heart healthcare.

The winner, to be announced on November 17, will earn a place in the AHA's Center for Health Technology & Innovation Innovators’ Network. This membership will provide invaluable resources, including mentorship and access to the latest digital health guidelines, empowering them to make their mark on the future of healthcare.

Robert A. Harrington, M.D., a leading figure in the AHA, stated, “The Center for Health Technology & Innovation is focused on fostering impactful solutions for critical health challenges. Collaboration within our network enhances the potential for breakthroughs that can address urgent health issues.”

As we look ahead, the advancements presented at this competition may very well dictate the future of cardiovascular care, leading to healthier lives for millions globally. Stay tuned, as the outcome of this competition could change the landscape of heart health innovations forever!